P. Acred

865 total citations
30 papers, 675 citations indexed

About

P. Acred is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, P. Acred has authored 30 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Infectious Diseases and 9 papers in Molecular Medicine. Recurrent topics in P. Acred's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). P. Acred is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). P. Acred collaborates with scholars based in United Kingdom, Canada and United States. P. Acred's co-authors include D. M. Brown, D. M. Ryan, P. B. Harper, R. Sutherland, Stuart M. Harding, Cynthia H. O'Callaghan, G. N. Rolinson, Elisa Knudsen, David H. Turner and Matthew Wilson and has published in prestigious journals such as Nature, The Lancet and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P. Acred

30 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Acred United Kingdom 14 311 236 160 145 136 30 675
F. Leitner United States 12 394 1.3× 259 1.1× 138 0.9× 105 0.7× 118 0.9× 29 562
T. A. Pursiano United States 10 368 1.2× 278 1.2× 121 0.8× 119 0.8× 116 0.9× 16 548
E. Schrinner Germany 14 361 1.2× 275 1.2× 150 0.9× 127 0.9× 115 0.8× 36 576
K. A. Bedford United Kingdom 13 448 1.4× 328 1.4× 174 1.1× 111 0.8× 97 0.7× 22 672
N. Klesel Germany 14 351 1.1× 216 0.9× 125 0.8× 87 0.6× 159 1.2× 36 604
Robert R. Bower United States 11 217 0.7× 149 0.6× 217 1.4× 102 0.7× 162 1.2× 16 535
M Misiek United States 11 346 1.1× 226 1.0× 102 0.6× 85 0.6× 113 0.8× 26 497
M. Limbert Germany 18 464 1.5× 298 1.3× 146 0.9× 115 0.8× 229 1.7× 43 832
Takeo Murakawa Japan 17 371 1.2× 208 0.9× 72 0.5× 107 0.7× 244 1.8× 36 658
C W Hanson United States 14 257 0.8× 205 0.9× 316 2.0× 265 1.8× 189 1.4× 20 708

Countries citing papers authored by P. Acred

Since Specialization
Citations

This map shows the geographic impact of P. Acred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Acred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Acred more than expected).

Fields of papers citing papers by P. Acred

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Acred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Acred. The network helps show where P. Acred may publish in the future.

Co-authorship network of co-authors of P. Acred

This figure shows the co-authorship network connecting the top 25 collaborators of P. Acred. A scholar is included among the top collaborators of P. Acred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Acred. P. Acred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McColm, A. A., et al.. (1990). Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants of Streptococcus sanguis II. Journal of Antimicrobial Chemotherapy. 25(1). 103–109. 13 indexed citations
2.
Ferguson, David, A. A. McColm, & P. Acred. (1990). A morphological comparison of treatment with different beta-lactam antibiotics on experimental staphylococcal endocarditis and aortitis.. PubMed. 71(5). 647–58. 3 indexed citations
3.
Ferguson, David, et al.. (1988). A morphological study of the effect of treatment with the antibiotic ceftazidime on experimental staphylococcal endocarditis and aortitis.. PubMed. 69(4). 551–61. 3 indexed citations
4.
Ferguson, David, et al.. (1986). A morphological study of experimental staphylococcal endocarditis and aortitis. II. Inter-relationship of bacteria, vegetation and cardiovasculature in established infections.. PubMed. 67(5). 679–86. 14 indexed citations
5.
Ferguson, David, et al.. (1986). A morphological study of experimental rabbit staphylococcal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetations on the aorta.. PubMed. 67(5). 667–78. 20 indexed citations
6.
McColm, A. A., D. M. Ryan, & P. Acred. (1984). Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits. Journal of Antimicrobial Chemotherapy. 14(4). 373–377. 7 indexed citations
7.
Acred, P., et al.. (1981). The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new  -lactam antibiotics and gentamicin. Journal of Antimicrobial Chemotherapy. 8(suppl B). 247–255. 8 indexed citations
8.
O'Callaghan, Cynthia H., et al.. (1980). GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrobial Agents and Chemotherapy. 17(5). 876–883. 153 indexed citations
9.
Acred, P., et al.. (1979). G1549, a new cyclic hydroxamic acid antibiotic, isolated from culture broth of Pseudomonas alcaligenes.. The Journal of Antibiotics. 32(11). 1096–1103. 24 indexed citations
10.
Acred, P., et al.. (1970). The distribution of antibacterial agents between plasma and lymph in the dog. British Journal of Pharmacology. 39(2). 439–446. 22 indexed citations
11.
Acred, P., et al.. (1963). A New Approach to Studying the Protein-Binding Properties of Penicillins. Nature. 199(4895). 758–759. 27 indexed citations
12.
Acred, P. & D. M. Brown. (1963). FURTHER PHARMACOLOGY AND CHEMOTHERAPY OF CLOXACILLIN. British Journal of Pharmacology and Chemotherapy. 21(2). 339–354. 4 indexed citations
13.
Acred, P., D. M. Brown, David H. Turner, & Matthew Wilson. (1962). PHARMACOLOGY AND CHEMOTHERAPY OF AMPICILLIN—A NEW BROAD‐SPECTRUM PENICILLIN. British Journal of Pharmacology and Chemotherapy. 18(2). 356–369. 75 indexed citations
14.
Nayler, J. H. C., D. M. Brown, P. Acred, et al.. (1962). Chemistry, Toxicology, Pharmacology and Microbiology of a new Acid-Stable Penicillin, Resistant to Penicillinase (BRL.1621). Nature. 195(4848). 1264–1267. 33 indexed citations
15.
Marley, E., G. V. R. Born, John R. Vane, et al.. (1961). PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY. British Journal of Pharmacology and Chemotherapy. 16(1). 1–5. 4 indexed citations
16.
Brown, D. M. & P. Acred. (1961). "Penbritin"--A New Broad-spectrum Antibiotic. BMJ. 2(5246). 197–198. 24 indexed citations
17.
Acred, P., D. M. Brown, David H. Turner, & D. J. Wright. (1961). PHARMACOLOGY OF METHICILLIN. British Journal of Pharmacology and Chemotherapy. 17(1). 70–81. 10 indexed citations
18.
Brown, D. M. & P. Acred. (1960). CHEMOTHERAPEUTIC STUDIES ON A NEW ANTIBIOTIC—BRL.1241. The Lancet. 276(7150). 568–569. 12 indexed citations
19.
Acred, P., D. M. Brown, & Dennis L. Wright. (1960). THE ANTITUBERCULAR ACTIVITY OF 3‐ACETYLTHIO‐PROPYLENE SULPHIDE AND 3‐(2‐FUROYLTHIO)PROPYLENE SULPHIDE. British Journal of Pharmacology and Chemotherapy. 15(4). 496–499. 1 indexed citations
20.
Acred, P., et al.. (1957). PHARMACOLOGICAL PROPERTIES OF ESTERS OF 1‐ALKYL‐2‐HYDROXYALKYLPYRROLIDINE AND THEIR QUATERNARY DERIVATIVES. British Journal of Pharmacology and Chemotherapy. 12(4). 447–452. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Leitner Breakdown of academic impact, for papers by T. A. Pursiano Breakdown of academic impact, for papers by E. Schrinner Breakdown of academic impact, for papers by K. A. Bedford Breakdown of academic impact, for papers by N. Klesel Breakdown of academic impact, for papers by Robert R. Bower Breakdown of academic impact, for papers by M Misiek Breakdown of academic impact, for papers by M. Limbert Breakdown of academic impact, for papers by Takeo Murakawa Breakdown of academic impact, for papers by C W Hanson
Rankless by CCL
2026